HGC019 is a mRNA and Self-amplifying mRNA based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with active support from NIH under The Indo-US Vaccine Action Program and Department of Biotechnology, India. Wikipedia